Expanded use case analysis for rapid antigen diagnostics for SARS-CoV-2 mitigation. Phase 2 results from the ACT-Accelerator SARS-CoV-2 rapid antigen testing modelling consortium.
![](https://www.dxkhub.org/wp-content/uploads/2023/02/Picture-2-Man-1200x801.jpeg)
Expanded use case analysis for rapid antigen diagnostics for SARS-CoV-2 mitigation. Phase 2 results from the ACT-Accelerator SARS-CoV-2 rapid antigen testing modelling consortium.
Expanded use case analysis for Phase 1 Results from the ACT-Accelerator SARS-COV-2 Rapid Antigen testing Modelling Consortium Rapid antigen diagnostics for SARS-CoV-2 mitigation.